Artigos de revistas sobre o tema "PDE2A"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "PDE2A".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Skryabin, Egor B., Kirstie A. De Jong, Hariharan Subramanian, Nadja I. Bork, Alexander Froese, Boris V. Skryabin e Viacheslav O. Nikolaev. "CRISPR/Cas9 Knock-Out in Primary Neonatal and Adult Cardiomyocytes Reveals Distinct cAMP Dynamics Regulation by Various PDE2A and PDE3A Isoforms". Cells 12, n.º 11 (4 de junho de 2023): 1543. http://dx.doi.org/10.3390/cells12111543.
Texto completo da fonteIvey, F. Douglas, Lili Wang, Didem Demirbas, Christina Allain e Charles S. Hoffman. "Development of a Fission Yeast-Based High-Throughput Screen to Identify Chemical Regulators of cAMP Phosphodiesterases". Journal of Biomolecular Screening 13, n.º 1 (26 de novembro de 2007): 62–71. http://dx.doi.org/10.1177/1087057107312127.
Texto completo da fonteManns, J. M., K. J. Brennan, S. B. Sheth e R. W. Colman. "Differential Regulation of Human Platelet Responses by cGMP Inhibited and Stimulated cAMP Phosphodiesterases". Thrombosis and Haemostasis 87, n.º 05 (2002): 873–79. http://dx.doi.org/10.1055/s-0037-1613099.
Texto completo da fonteCarvalho, Thays Maria da Conceição Silva, Silvia Cardarelli, Mauro Giorgi, Andrea Lenzi, Andrea M. Isidori e Fabio Naro. "Phosphodiesterases Expression during Murine Cardiac Development". International Journal of Molecular Sciences 22, n.º 5 (5 de março de 2021): 2593. http://dx.doi.org/10.3390/ijms22052593.
Texto completo da fonteChen, Ling, Suying Cui, Haiyang Yu, Gaowen Li, Na Liu, Qiang Wu, Han-Ting Zhang, James M. O’Donnell, Gang Wang e Ying Xu. "Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice". Journal of Psychopharmacology 33, n.º 5 (5 de março de 2019): 568–76. http://dx.doi.org/10.1177/0269881119832753.
Texto completo da fonteChen, Lin, Jinchi Zhou, Zifeng Zhao, Yuhan Zhu, Jinliang Xing, Jiaze An e Xu Guo. "Low Expression of Phosphodiesterase 2 (PDE2A) Promotes the Progression by Regulating Mitochondrial Morphology and ATP Content and Predicts Poor Prognosis in Hepatocellular Carcinoma". Cells 12, n.º 1 (23 de dezembro de 2022): 68. http://dx.doi.org/10.3390/cells12010068.
Texto completo da fonteBarbagallo, Federica, Valentina Rotilio, Maria Rita Assenza, Salvatore Aguanno, Tiziana Orsini, Sabrina Putti, Andrea M. Isidori et al. "PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis". International Journal of Molecular Sciences 21, n.º 8 (21 de abril de 2020): 2902. http://dx.doi.org/10.3390/ijms21082902.
Texto completo da fonteMatthiesen, Karina, e Jacob Nielsen. "Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity". Biochemical Journal 423, n.º 3 (12 de outubro de 2009): 401–9. http://dx.doi.org/10.1042/bj20090982.
Texto completo da fonteRitawidya, Ludwig, Briel, Brust e Scheunemann. "Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors". Molecules 24, n.º 15 (31 de julho de 2019): 2791. http://dx.doi.org/10.3390/molecules24152791.
Texto completo da fonteRentsendorj, Otgonchimeg, Mahendra Damarla, Neil R. Aggarwal, Ji-Young Choi, Laura Johnston, Franco R. D'Alessio, Michael T. Crow e David B. Pearse. "Knockdown of lung phosphodiesterase 2A attenuates alveolar inflammation and protein leak in a two-hit mouse model of acute lung injury". American Journal of Physiology-Lung Cellular and Molecular Physiology 301, n.º 2 (agosto de 2011): L161—L170. http://dx.doi.org/10.1152/ajplung.00073.2011.
Texto completo da fonteJiang, Lei, e Shenghu Yan. "Prokaryotic Expression, Purification and Activity Detection of Phosphodiesterase 2A Protein". Journal of Biology and Life Science 11, n.º 2 (16 de abril de 2020): 1. http://dx.doi.org/10.5296/jbls.v11i2.16650.
Texto completo da fonteKubacka, Monika, Szczepan Mogilski, Marek Bednarski, Krzysztof Pociecha, Artur Świerczek, Noemi Nicosia, Jakub Schabikowski et al. "Antiplatelet Effects of Selected Xanthine-Based Adenosine A2A and A2B Receptor Antagonists Determined in Rat Blood". International Journal of Molecular Sciences 24, n.º 17 (29 de agosto de 2023): 13378. http://dx.doi.org/10.3390/ijms241713378.
Texto completo da fonteWenzel, Barbara, Stefan R. Fritzsche, Magali Toussaint, Detlef Briel, Klaus Kopka, Peter Brust, Matthias Scheunemann e Winnie Deuther-Conrad. "Radiosynthesis and Preclinical Evaluation of an 18F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)". Pharmaceuticals 15, n.º 10 (15 de outubro de 2022): 1272. http://dx.doi.org/10.3390/ph15101272.
Texto completo da fonteKallenborn-Gerhardt, Wiebke, Ruirui Lu, Aaron Bothe, Dominique Thomas, Jessica Schlaudraff, Jana E. Lorenz, Nancy Lippold et al. "Phosphodiesterase 2A Localized in the Spinal Cord Contributes to Inflammatory Pain Processing". Anesthesiology 121, n.º 2 (1 de agosto de 2014): 372–82. http://dx.doi.org/10.1097/aln.0000000000000270.
Texto completo da fonteMaurin, Thomas, Francesca Melancia, Marielle Jarjat, Liliana Castro, Lara Costa, Sébastien Delhaye, Anouar Khayachi et al. "Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome". Cerebral Cortex 29, n.º 8 (23 de agosto de 2018): 3241–52. http://dx.doi.org/10.1093/cercor/bhy192.
Texto completo da fonteXu, Ying, Jianchun Pan, Ling Chen, Chong Zhang, Jiao Sun, Jianxin Li, Linda Nguyen, Neetu Nair, Hanting Zhang e James M. O'Donnell. "Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway". International Journal of Neuropsychopharmacology 16, n.º 4 (1 de maio de 2013): 835–47. http://dx.doi.org/10.1017/s146114571200065x.
Texto completo da fonteRassi-Cruz, Marcela, Andrea G. Maria, Fabio R. Faucz, Edra London, Leticia A. P. Vilela, Lucas S. Santana, Anna Flavia F. Benedetti et al. "Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism". Endocrine-Related Cancer 28, n.º 1 (janeiro de 2021): 1–13. http://dx.doi.org/10.1530/erc-20-0384.
Texto completo da fonteNakashima, Kosuke, e Hideki Matsui. "A Novel Inhibition Modality for Phosphodiesterase 2A". SLAS DISCOVERY: Advancing the Science of Drug Discovery 25, n.º 5 (28 de abril de 2020): 498–505. http://dx.doi.org/10.1177/2472555220913241.
Texto completo da fonteLi, Dan, Kun Liu, Harvey Davis, Calum Robertson, Oliver C. Neely, Adib Tarafdar, Ni Li, Konstantinos Lefkimmiatis, Manuela Zaccolo e David J. Paterson. "Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension". Hypertension 79, n.º 7 (julho de 2022): 1374–84. http://dx.doi.org/10.1161/hypertensionaha.121.18882.
Texto completo da fonteRitawidya, Wenzel, Teodoro, Toussaint, Kranz, Deuther-Conrad, Dukic-Stefanovic, Ludwig, Scheunemann e Brust. "Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine- Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography". Molecules 24, n.º 22 (15 de novembro de 2019): 4149. http://dx.doi.org/10.3390/molecules24224149.
Texto completo da fonteGong, Wei, Lei Yang, Yuanyuan Wang, Jianfeng Xian, Fuman Qiu, Li Liu, Mingzhu Lin, Yingyi Feng, Yifeng Zhou e Jiachun Lu. "Analysis of Survival-Related lncRNA Landscape Identifies A Role for LINC01537 in Energy Metabolism and Lung Cancer Progression". International Journal of Molecular Sciences 20, n.º 15 (1 de agosto de 2019): 3713. http://dx.doi.org/10.3390/ijms20153713.
Texto completo da fonteLu, Jia Yang, e Marion B. Sewer. "p54nrb/NONO Regulates Cyclic AMP-Dependent Glucocorticoid Production by Modulating Phosphodiesterase mRNA Splicing and Degradation". Molecular and Cellular Biology 35, n.º 7 (20 de janeiro de 2015): 1223–37. http://dx.doi.org/10.1128/mcb.00993-14.
Texto completo da fonteKeefer, Christopher E., e George Chang. "The use of matched molecular series networks for cross target structure activity relationship translation and potency prediction". MedChemComm 8, n.º 11 (2017): 2067–78. http://dx.doi.org/10.1039/c7md00465f.
Texto completo da fonteTanaka, Saori, Rina Tanaka, Saeko Harada, Yuka Kohda, Hitoshi Matsumura, Chikao Shimamoto, Yukinori Sawabe et al. "A PKG inhibitor increases Ca2+-regulated exocytosis in guinea pig antral mucous cells: cAMP accumulation via PDE2A inhibition". American Journal of Physiology-Gastrointestinal and Liver Physiology 304, n.º 9 (1 de maio de 2013): G773—G780. http://dx.doi.org/10.1152/ajpgi.00281.2012.
Texto completo da fonteDing, Hao, Xiao-Xing Xiong, Guan-Lan Fan, Yue-Xiong Yi, Yu-Rou Chen, Jing-Tao Wang e Wei Zhang. "The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining". BioMed Research International 2020 (13 de abril de 2020): 1–9. http://dx.doi.org/10.1155/2020/5478574.
Texto completo da fonteRusswurm, Corina, Georg Zoidl, Doris Koesling e Michael Russwurm. "Dual Acylation of PDE2A Splice Variant 3". Journal of Biological Chemistry 284, n.º 38 (24 de julho de 2009): 25782–90. http://dx.doi.org/10.1074/jbc.m109.017194.
Texto completo da fonteWang, Jianjie, Susan Bingaman e Virginia H. Huxley. "Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases". American Journal of Physiology-Heart and Circulatory Physiology 298, n.º 4 (abril de 2010): H1146—H1154. http://dx.doi.org/10.1152/ajpheart.00252.2009.
Texto completo da fonteSchmidt, Eric P., Mahendra Damarla, Otgonchimeg Rentsendorj, Laura E. Servinsky, Bing Zhu, Aigul Moldobaeva, Alfredo Gonzalez, Paul M. Hassoun e David B. Pearse. "Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice". American Journal of Physiology-Lung Cellular and Molecular Physiology 295, n.º 6 (dezembro de 2008): L1056—L1065. http://dx.doi.org/10.1152/ajplung.90329.2008.
Texto completo da fonteWang, Junnan, Mingyi Wu, Xiaowen Lin, Yun Li e Zhijian Fu. "Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-κB/p65 Signaling in Chronic Radiculitis Rats". Pain Research and Management 2018 (13 de dezembro de 2018): 1–8. http://dx.doi.org/10.1155/2018/5192814.
Texto completo da fonteDurand, Julien, Antoine Lampron, Tania L. Mazzuco, Audrey Chapman e Isabelle Bourdeau. "Characterization of Differential Gene Expression in Adrenocortical Tumors Harboring β-Catenin (CTNNB1) Mutations". Journal of Clinical Endocrinology & Metabolism 96, n.º 7 (1 de julho de 2011): E1206—E1211. http://dx.doi.org/10.1210/jc.2010-2143.
Texto completo da fonteFryknäs, Mårten, Linda Rickardson, Malin Wickström, Sumeer Dhar, Henrik Lövborg, Joachim Gullbo, Peter Nygren, Mats G. Gustafsson, Anders Isaksson e Rolf Larsson. "Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model". Journal of Biomolecular Screening 11, n.º 5 (28 de abril de 2006): 457–68. http://dx.doi.org/10.1177/1087057106288048.
Texto completo da fonteJuilfs, D. M., W. K. Sonnenburg, S. Seraji, H.-I. Fülle, D. L. Garbers, M. D. Houslay e J. A. Beavo. "IDENTIFICATION OF A NEW PDE2A ISOFORM AND EXPRESSION OF PDE2 IN A SUBSET OF OLFACTORY NEURONS & GASTROINTESTINAL CELLS". Biochemical Society Transactions 24, n.º 4 (1 de novembro de 1996): 624S. http://dx.doi.org/10.1042/bst024624s.
Texto completo da fonteMontoya-Durango, Diego, Mary Nancy Walter, Walter Rodriguez, Yali Wang, Julia H. Chariker, Eric C. Rouchka, Claudio Maldonado, Shirish Barve, Craig J. McClain e Leila Gobejishvili. "Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies". Biology 12, n.º 10 (10 de outubro de 2023): 1321. http://dx.doi.org/10.3390/biology12101321.
Texto completo da fontePetersen, Tonny Studsgaard, Martin Stahlhut e Claus Yding Andersen. "Phosphodiesterases in the rat ovary: effect of cAMP in primordial follicles". REPRODUCTION 150, n.º 1 (julho de 2015): 11–20. http://dx.doi.org/10.1530/rep-14-0436.
Texto completo da fonteMa, Y. S., Y. H. Xie, D. Ma, J. J. Zhang e H. J. Liu. "Shear stress-induced MMP1 and PDE2A expressions in coronary atherosclerosis". Bratislava Medical Journal 122, n.º 04 (2021): 287–92. http://dx.doi.org/10.4149/bll_2021_048.
Texto completo da fonteDoummar, Diane, Christel Dentel, Romane Lyautey, Julia Metreau, Boris Keren, Nathalie Drouot, Ludivine Malherbe et al. "Biallelic PDE2A variants: a new cause of syndromic paroxysmal dyskinesia". European Journal of Human Genetics 28, n.º 10 (28 de maio de 2020): 1403–13. http://dx.doi.org/10.1038/s41431-020-0641-9.
Texto completo da fonteAdderley, Shaquria P., Eileen A. Dufaux, Meera Sridharan, Elizabeth A. Bowles, Madelyn S. Hanson, Alan H. Stephenson, Mary L. Ellsworth e Randy S. Sprague. "Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans". American Journal of Physiology-Heart and Circulatory Physiology 296, n.º 5 (maio de 2009): H1617—H1624. http://dx.doi.org/10.1152/ajpheart.01226.2008.
Texto completo da fonteTrabanco, Andrés A., Peter Buijnsters e Frederik J. R. Rombouts. "Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present)". Expert Opinion on Therapeutic Patents 26, n.º 8 (30 de junho de 2016): 933–46. http://dx.doi.org/10.1080/13543776.2016.1203902.
Texto completo da fonteFarmer, Reagan, Steven D. Burbano, Neema S. Patel, Angelo Sarmiento, Abigail J. Smith e Michy P. Kelly. "Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease". Cellular Signalling 70 (junho de 2020): 109592. http://dx.doi.org/10.1016/j.cellsig.2020.109592.
Texto completo da fonteFernández-Fernández, Diego, Holger Rosenbrock e Katja S. Kroker. "Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus". Synapse 69, n.º 10 (29 de julho de 2015): 484–96. http://dx.doi.org/10.1002/syn.21840.
Texto completo da fonteZlobin, Alexander S., Natalia A. Volkova, Natalia A. Zinovieva, Baylar S. Iolchiev, Vugar A. Bagirov, Pavel M. Borodin, Tatiana I. Axenovich e Yakov A. Tsepilov. "Loci Associated with Negative Heterosis for Viability and Meat Productivity in Interspecific Sheep Hybrids". Animals 13, n.º 1 (3 de janeiro de 2023): 184. http://dx.doi.org/10.3390/ani13010184.
Texto completo da fonteNaganawa, M., R. N. Waterhouse, N. Nabulsi, S. F. Lin, D. Labaree, J. Ropchan, S. Tarabar et al. "First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430". Journal of Nuclear Medicine 57, n.º 9 (21 de abril de 2016): 1388–95. http://dx.doi.org/10.2967/jnumed.115.166850.
Texto completo da fonteHaidar, Zahraa, Nadine Jalkh, Sandra Corbani, Joelle Abou‐Ghoch, Ali Fawaz, Cybel Mehawej e Eliane Chouery. "A Homozygous Splicing Mutation in PDE2A in a Family With Atypical Rett Syndrome". Movement Disorders 35, n.º 5 (20 de março de 2020): 896–99. http://dx.doi.org/10.1002/mds.28023.
Texto completo da fonteWunder, Frank, Mark Jean Gnoth, Andreas Geerts e Daniel Barufe. "A Novel PDE2A Reporter Cell Line: Characterization of the Cellular Activity of PDE Inhibitors". Molecular Pharmaceutics 6, n.º 1 (2 de dezembro de 2008): 326–36. http://dx.doi.org/10.1021/mp800127n.
Texto completo da fonteSalpietro, Vincenzo, Belen Perez-Dueñas, Kosuke Nakashima, Victoria San Antonio-Arce, Andreea Manole, Stephanie Efthymiou, Jana Vandrovcova et al. "A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea". Movement Disorders 33, n.º 3 (2 de fevereiro de 2018): 482–88. http://dx.doi.org/10.1002/mds.27286.
Texto completo da fonteClaire, Nicolas, Shittl Julia, Pertuiset Claire, Mehel Hind, Courilleau Delphine, Jullian Jean-Christophe, Cresteil Thierry et al. "0310 Assay development and high-throughput screening to identify PDE2A activators to treat heart failure". Archives of Cardiovascular Diseases Supplements 6 (abril de 2014): 43. http://dx.doi.org/10.1016/s1878-6480(14)71379-5.
Texto completo da fonteZhang, Zhao-Xiong, Qiang Han e Shu-Ye Liu. "Clinical significance of PDE2A in prognosis and immune infiltration in gastrointestinal cancer based on bioinformatics analysis". World Chinese Journal of Digestology 29, n.º 18 (28 de setembro de 2021): 1055–63. http://dx.doi.org/10.11569/wcjd.v29.i18.1055.
Texto completo da fonteLi, San-Zhong, Kai-Xi Ren, Jing Zhao, Shuang Wu, Juan Li, Jian Zang, Zhou Fei e Jun-Long Zhao. "miR-139/PDE2A-Notch1 feedback circuit represses stemness of gliomas by inhibiting Wnt/β-catenin signaling". International Journal of Biological Sciences 17, n.º 13 (2021): 3508–21. http://dx.doi.org/10.7150/ijbs.62858.
Texto completo da fonteSadhu, Krishna, Kelly Hensley, Vince A. Florio e Sharon L. Wolda. "Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells". Journal of Histochemistry & Cytochemistry 47, n.º 7 (julho de 1999): 895–905. http://dx.doi.org/10.1177/002215549904700707.
Texto completo da fonteCann, M. J. "Sodium regulation of GAF domain function". Biochemical Society Transactions 35, n.º 5 (25 de outubro de 2007): 1032–34. http://dx.doi.org/10.1042/bst0351032.
Texto completo da fonte